NCT02927249
Clinical Trial Information
Trial Number: NCT02927249 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
"A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial"
Study ID:
A011502
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02927249-D2 | Dataset NCT02927249-D2 is one of 2 datasets associated with PubMed ID 38683596. This dataset contains data presented in the Grade 3 or higher adverse event table (Table 3). NCT02927249-D1 contains data presented in the baseline characteristics table, primary analysis, and dose modification information. |
| NCT02927249-D1 | Dataset NCT02927249-D1 is one of 2 datasets associated with PubMed ID 38683596. This dataset contains data presented in the baseline characteristics table, primary analysis, and dose modification information. NCT02927249-D2 contains data presented in the Grade 3 or higher adverse event table (Table 3). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®